表紙:バイオチップの市場予測・競合動向・成長機会 (~2026年):技術・タイプ・用途・エンドユーザー・地域別
市場調査レポート
商品コード
1002700

バイオチップの市場予測・競合動向・成長機会 (~2026年):技術・タイプ・用途・エンドユーザー・地域別

Global Biochip Market, By Technology, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 206 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

バイオチップの市場予測・競合動向・成長機会 (~2026年):技術・タイプ・用途・エンドユーザー・地域別
出版日: 2021年07月01日
発行: TechSci Research
ページ情報: 英文 206 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオチップの市場規模は2020年に116億9424万米ドルの規模を示し、2026年には238億9058万米ドルの規模に成長すると予測されています。

さまざまな慢性疾患や感染症の蔓延、特に癌などの疾患に対する個別化医療や標的治療の需要の拡大、R&Dの活発化、政府の支援政策などの要因が同市場の成長を推進しています。一方で、バイオチップのコストの高さ、新興諸国における認知度の低さ、各国政府による厳しい法規制などの要因が市場のさらなる成長の妨げとなっています。

技術別では、マイクロアレイ技術が法医学的分析や創薬プロセスにおける薬剤候補の同定に幅広く利用されていることから、予測期間中の市場をリードすると予測されています。一方で、妊娠キット、心臓メーカー、血液ガスなどのPOC診断機器の使用が増加していることから、マイクロフルイディクス技術が今後数年で高いCAGRを記録すると予測されています。

当レポートでは、世界のバイオチップの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、技術・タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 顧客の声

第5章 エグゼクティブサマリー

第6章 世界市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
    • マイクロアレイ
    • マイクロフルイディクス
  • タイプ別
    • DNAチップ
    • ラボオンチップ
    • プロテインチップ
    • その他
  • 用途別
    • 創薬・開発
    • 疾患診断
    • ゲノミクス
    • プロテオミクス
    • その他
  • エンドユーザー別
    • バイオ&製薬企業
    • 病院・診断センター
    • 学術・研究機関
    • その他
  • 企業別
  • 地域別
  • 製品市場マップ

第7章 北米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第8章 欧州市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第9章 アジア太平洋市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第10章 南米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第11章 中東・アフリカ市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
  • 技術別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 競合情勢

  • 競合の展望
  • 企業プロファイル

第15章 戦略的提言

第16章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Research & Development Expenditure of Top 5 Countries (USD Billion), As of 2021
  • Figure 3: Global Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 4: Global Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 5: Global Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 6: Global Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 7: Global Biochip Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Biochip Market Share, By Company, By Value, 2020
  • Figure 9: Global Biochip Market Map, By Technology, Market Size (USD Million) & Growth Rate (%)
  • Figure 10: Global Biochip Market Map, By Type, Market Size (USD Million) & Growth Rate (%)
  • Figure 11: North America Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 12: North America Undiagnosed and Diagnosed Diabetes Cases, 2019
  • Figure 13: North America Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 14: North America Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 15: North America Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 16: North America Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 17: North America Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 18: United States Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 19: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 20: United States Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 21: United States Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 22: United States Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 23: United States Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 24: Canada Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 25: Canada Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 26: Canada Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 27: Canada Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 28: Canada Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 29: Canada Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 30: Mexico Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 31: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 32: Mexico Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 33: Mexico Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 34: Mexico Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 35: Mexico Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 36: Europe Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 37: Leading Cancers in Males in Europe by Incidence and Mortality Common Cancers, 2020
  • Figure 38: Europe Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 39: Europe Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 40: Europe Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 41: Europe Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 42: Europe Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 43: United Kingdom Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 44: Geriatric Population Numbers & Projections in United Kingdom (Millions), 2020
  • Figure 45: United Kingdom Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 46: United Kingdom Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 47: United Kingdom Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 48: United Kingdom Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 49: Germany Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 50: Germany New Cancer Cases, By Type, 2020
  • Figure 51: Germany Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 52: Germany Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 53: Germany Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 54: Germany Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 55: France Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 56: France Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 57: France Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 58: France Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 59: France Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 60: France Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Italy Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: Italy Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 63: Italy Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 64: Italy Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 65: Italy Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 66: Italy Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 67: Spain Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 68: Number of New Cancer Cases in Spain, By Cancer Site, 2020
  • Figure 69: Spain Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 70: Spain Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 71: Spain Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 72: Spain Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 73: Asia Pacific Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 74: Number of New Cancer Cases in Asia Pacific (2020)
  • Figure 75: Asia Pacific Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 76: Asia Pacific Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 77: Asia Pacific Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 78: Asia Pacific Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 79: Asia Pacific Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 80: China Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 81: China Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 82: China Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 83: China Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 84: China Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 85: China Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 86: Japan Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 87: Japan Total Health Expenditure as a share of GDP, 2015- 2019
  • Figure 88: Japan Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 89: Japan Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 90: Japan Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 91: Japan Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 92: India Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: Growing Share of Geriatric Population (Above 60 Years) in India (2015-2019)
  • Figure 94: India Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 95: India Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 96: India Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 97: India Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 98: South Korea Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 99: New Cancer Cases in South Korea (%), 2019
  • Figure 100: South Korea Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 101: South Korea Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 102: South Korea Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 103: South Korea Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 104: Australia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 105: Australia Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 106: Australia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 107: Australia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 108: Australia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 109: Australia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 110: South America Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 111: Central and South America Diagnosed and Undiagnosed Diabetes Cases, 2019
  • Figure 112: South America Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 113: South America Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 114: South America Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 115: South America Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 116: South America Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 117: Brazil Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 118: Brazil Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 119: Brazil Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 120: Brazil Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 121: Brazil Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 122: Brazil Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 123: Argentina Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 124: Argentina Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 125: Argentina Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 126: Argentina Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 127: Argentina Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 128: Argentina Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 129: Colombia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 130: New Cancer Cases in Colombia (%), 2019
  • Figure 131: Colombia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 132: Colombia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 133: Colombia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 134: Colombia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 135: Middle East & Africa Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 136: Middle East & Africa Geriatric Population Base (Age 60 & Above) % of Total Population, 2015-2019
  • Figure 137: Middle East & Africa Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 138: Middle East & Africa Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 139: Middle East & Africa Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 140: Middle East & Africa Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 141: Middle East & Africa Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 142: South Africa Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 143: South Africa New Cancer Cases, By Type, 2020
  • Figure 144: South Africa Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 145: South Africa Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 146: South Africa Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 147: South Africa Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 148: Saudi Arabia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 149: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 150: Saudi Arabia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 151: Saudi Arabia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 152: Saudi Arabia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 153: Saudi Arabia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 154: UAE Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 155: % of female population in UAE, 2015-2019
  • Figure 156: UAE Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 157: UAE Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 158: UAE Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 159: UAE Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 160: Global Population Ages 65 & Above (% of Total Population), 2016-2019
  • Figure 161: Number of Deaths Caused due to Selected Chronic Diseases in 2019 (in Thousands)
目次
Product Code: 1259

Global biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by 2026, registering a CAGR of 12.52% in the next five years. The global biochip market is driven by the growing prevalence of various chronic and infectious diseases especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in demand for personalized medicine solutions or targeted therapies especially for diagnosis and treatment of diseases like cancer. This in turn is expected to positively influence the market growth over the next few years. Additionally, increasing R&D activities and supportive government policies further propels the market. However, the high cost of biochips can hamper market growth. Moreover, lack of awareness, especially in the developing and underdeveloped countries, further impedes the market growth.

The global biochip market is segmented based on technology, type, application, end user, company, and region. Based on technology, the market can be bifurcated into microarray and microfluidics. The microarray technology dominated the market in 2020 with a share of around 60.22% and is expected to dominate the market during the forecast period also. This can be attributed to the extensive use of biochips in forensic analysis and identification of drug candidates in the drug discovery process. While the microfluidics technology is expected to witness significant growth over the next few years on account of the increasing use of point of care diagnostic devices such as pregnancy kits, cardiac makers, and blood gases, among others. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips, Protein Chips and others. The DNA chips segment is expected to dominate the market during the forecast period. This can be ascribed to the widespread adoption of DNA chips. Additionally, growing expenditure related to genomics and next-generation sequencing along with rising demand for detection and diagnosis of genetic disorders is further expected to support the market growth.

Regionally, North America represented a major share of the global market and is anticipated to continue its dominance in the forecast period. This is directly related to a rise in cancer incidence in the region. In 2020, cancers such as, prostate, lung, and colorectal accounted for approximately 43% of all cancers diagnosed in men. In case of women, breast, lung, and colorectal cancers are the most common cancers and they account for an estimated 50% of all new cancer diagnosed in women in the year 2020. Additionally, growing burden of different diseases is further expected to fuel the market growth.

The major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioMerieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Cepheid (Danaher Corporation) and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers and acquisitions and new product developments. For instance, In March 2020, Agilent Technologies, Inc. developed three new GenetiSure Cyto microarrays for prenatal and postnatal research.

Years considered for this report:

  • Historical Year: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global biochip market from 2016 to 2020.
  • To estimate and forecast the market size of the global biochip market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the global biochip market based on type, technology, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the global biochip market.
  • To identify drivers and challenges for the global biochip market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global biochip market.
  • To conduct pricing analysis for the global biochip market.
  • To identify and analyze the profile of leading players operating in the global biochip market.
  • To identify key sustainable strategies adopted by market players in the global biochip market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global biochip market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biochip manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to biochips

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global biochip market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Biochip Market, By Technology:

  • Microarray
  • Microfluidics

Global Biochip Market, By Type:

  • DNA Chips
  • Lab-On-a-Chips
  • Protein Chips
  • Others

Global Biochip Market, By Application:

  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Others

Global Biochip Market, By End User:

  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Global Biochip Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global biochip market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Biochip Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Major Benefits of Using Biochips
  • 5.3. Preferred Biochips, Based on Technology

6. Global Biochip Market Outlook, 2016-2026F

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Microarray v/s Microfluidics)
    • 6.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
    • 6.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others)
    • 6.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2020)
  • 6.3. Product Market Map

7. North America Biochip Market Outlook, 2016-2026F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Biochip Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Biochip Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Biochip Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Biochip Market Outlook, 2016-2026F

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. United Kingdom Biochip Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Biochip Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. France Biochip Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Biochip Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Biochip Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Biochip Market Outlook, 2016-2026F

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Biochip Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Japan Biochip Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. India Biochip Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Biochip Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Technology
        • 9.3.4.2.2. By Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Biochip Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Technology
        • 9.3.5.2.2. By Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Biochip Market Outlook, 2016-2026F

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biochip Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Biochip Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Biochip Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Biochip Market Outlook, 2016-2026F

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Biochip Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Biochip Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Biochip Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Abbott Laboratories Inc.
    • 14.2.2. Agilent Technologies, Inc.
    • 14.2.3. PerkinElmer Inc.
    • 14.2.4. Fluidigm Corporation
    • 14.2.5. Illumina, Inc.
    • 14.2.6. GE Healthcare Inc.
    • 14.2.7. Bio-Rad Laboratories Inc.
    • 14.2.8. Thermo Fisher Scientific, Inc.
    • 14.2.9. F. Hoffmann-La Roche AG
    • 14.2.10. BioMerieux SA
    • 14.2.11. HORIBA, Ltd.
    • 14.2.12. QIAGEN N.V.
    • 14.2.13. Randox Laboratories Ltd.
    • 14.2.14. OriGene Technologies, Inc.
    • 14.2.15. Cepheid (Danaher Corporation)

15. Strategic Recommendations

16. About Us & Disclaimer